Pacific Biosciences
PACB
C$2.12
Share price
-6.10%
Change (1 day)
-25.32%
Change (1 year)
Categories
Pacific Biosciences (PACB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$1.05 Billion
According to Pacific Biosciences 's latest financial reports the company's total liabilities are C$1.05 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$1.08 B | -21.93% |
| 2023-12-31 | C$1.38 B | -15.2% |
| 2022-12-31 | C$1.63 B | 5.44% |
| 2021-12-31 | C$1.54 B | 1448.47% |
| 2020-12-31 | C$0.10 B | -17.67% |
| 2019-12-31 | C$0.12 B | 58.74% |
| 2018-12-31 | C$76.57 M | 5.05% |
| 2017-12-31 | C$72.89 M | 1.93% |
| 2016-12-31 | C$71.51 M | -10.45% |
| 2015-12-31 | C$79.85 M | -0.9% |
| 2014-12-31 | C$80.58 M | 12.98% |
| 2013-12-31 | C$71.32 M | 253.32% |
| 2012-12-31 | C$20.18 M | -26.09% |
| 2011-12-31 | C$27.31 M | 5.58% |
| 2010-12-31 | C$25.87 M | -91.16% |
| 2009-12-31 | C$0.29 B | 16.59% |
| 2008-12-31 | C$0.25 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | C$5.25 B | 395.87% | 🇺🇸 USA |
 NanoString Technologies NSTG | C$0.44 B | -57.71% | 🇺🇸 USA |
 General Electric GE | C$144.09 B | 13,506.56% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | C$68.23 B | 6,342.95% | 🇺🇸 USA |
 PerkinElmer
PKI | C$9.09 B | 758.65% | 🇺🇸 USA |